| Drug Name: | Zanamivir |
|---|
| Drug Class: | Neuraminidase inhibitor |
|---|
| Mechanism of Action: | Inhibits the neuraminidase enzyme, preventing the release of new viral particles from infected cells |
|---|
| Use: | - Treatment and prevention of influenza A and B viruses
- Prophylaxis in individuals aged 5 years and older
|
|---|
| Side Effects: | - Nasal and throat discomfort
- Cough
- Headache
- Bronchospasm (rare)
|
|---|
| Contraindications: | - Hypersensitivity to zanamivir or any component of the formulation
- Severe respiratory disease (e.g., asthma, chronic obstructive pulmonary disease)
|
|---|
| Specialty: | - Infectious Disease
- Pulmonology
|
|---|